Want to see AU:ZNO full AI Analyst Report?
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)153.26K
Market Cap
AU$24.37M
Enterprise ValueAU$26.15M
Total Cash (Recent Filing)AU$475.33K
Total Debt (Recent Filing)AU$625.70K
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Solvency CushioningThe company’s low debt burden reduces near-term solvency and interest-cost risk, giving management flexibility to weather continued losses. Structurally, lower leverage is a durable buffer that eases refinancing pressure and supports optionality for strategic investments or distribution expansion over months.
Diversified Channels And Repeat-demand ProductZoono’s core products target long‑term hygiene and infection‑control needs sold via both commercial and retail channels. That mix and exposure to repeat purchasing industries (facilities, transport, healthcare, retail) provide structural revenue durability and multiple routes to scale distribution over 2–6 months and beyond.
Positive Revenue Trend In FY2025Top‑line growth of ~14.8% in FY2025 shows recoveries in demand and potential product traction versus prior declines. While not large in absolute terms, sustained revenue momentum is a necessary prerequisite for achieving operating leverage and turning the business toward structural profitability over the medium term.
Bears Say
Deep And Persistent UnprofitabilityNegative gross profit and extreme net margins indicate the company is selling below full product cost or facing high fixed/operating expenses. This structural unprofitability erodes capital and implies the business model requires material margin improvement or cost restructuring before sustainable earnings can be achieved.
Consistent Negative Cash GenerationPersistent negative operating cash flow forces reliance on external financing and dilutive capital raises, constraining reinvestment and growth. Over a multi‑month horizon, continued cash burn increases financing risk, limits strategic choices, and weakens the company’s ability to execute distribution or product development plans sustainably.
Material Erosion Of Equity BaseA sharply reduced equity base removes a financial cushion against future losses and reduces borrowing capacity. Structurally, diminished shareholder equity heightens vulnerability to adverse shocks, increases probability of dilution to fund operations, and undermines long‑term resilience unless profitability is restored.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$24.37M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Aug 20, 2026 which is in 35 days.
How were Zoono Group Limited’s earnings last quarter?
Zoono Group Limited released its earnings results on Feb 19, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Zoono Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.18%
12-Months-Change
Fundamentals
Return on Equity
-108.90%
Trailing 12-Months
Asset Growth
-23.69%
Trailing 12-Months
Company Description
Zoono Group Limited
Zoono Group Limited, along with its associated entities, specializes in the innovation, development, and global distribution of a variety of antimicrobial solutions, catering to both the New Zealand market and international clientele. Their product line features items such as hand cleansers, specialized textile applications, mold remediation treatments, and surface disinfectants. Zoono provides its services to a broad spectrum of industries, including the aviation, medical, early education, facilities management, transportation, academic, and hospitality sectors. The firm was established in 1986 and maintains its principal operations from Auckland, New Zealand.
Technical Analysis
Pental Ltd.
―
Mcpherson'S Limited
―
―
EVE Health Group Limited
―
Skin Elements Limited
―